Economic effects of beta-blocker therapy in patients with heart failure

Studies suggest that beta-blockers improve outcomes in heart failure patients and may be cost saving to society. However, many heart failure patients are not treated with beta-blockers. Economic incentives facing hospitals, physicians, payers, and patients may not encourage treatment adoption. We as...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of medicine 2004-01, Vol.116 (2), p.104-111
Hauptverfasser:	Cowper, Patricia A, DeLong, Elizabeth R, Whellan, David J, Allen LaPointe, Nancy M, Califf, Robert M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-Antagonists - economics Adrenergic beta-Antagonists - therapeutic use Beta blockers Biological and medical sciences Cardiology. Vascular system Cost Savings Decision Trees Disease Progression Drug therapy Economics Fees, Medical General aspects Heart Heart failure Heart Failure - drug therapy Heart Failure - economics Heart Failure - mortality Heart failure, cardiogenic pulmonary edema, cardiac enlargement Hospital Costs - statistics & numerical data Hospitalization - economics Hospitalization - statistics & numerical data Hospitals, University - economics Humans Insurance, Health, Reimbursement Markov Chains Medical sciences Medicare - economics North Carolina Survival Analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!